|
|
Connecting People and Ideas for a Healthier World
Please click on the links below to see examples of Summit outcomes from previous years. More information on Summit outcomes from
2005-2010 will be updated regularly.
The 2010 Summit was a major milestone in the arc
of high-level events focusing attention to maternal and newborn health (MNH). For 95% of respondents to the post-meeting survey, this dialogue is leading to significant, promising collaborations and initiatives.
A Call for Collaboration by Aaron Oxley, Executive Director, Results UK resulted in data utilized in
recommendations
to the UK Government’s Maternal Mortality Business Plan Consultation. A partnership emerged between Powerfree Education and Technology (PET) and Laerdal to manufacture and distribute two innovative medical devices for MDG 4 and 5. The Summit also catalyzed the foundation of
Laerdal Global Health. Out of talks originating at the Summit, Laerdal Global Health
partnered
with Jhpiego, a Johns Hopkins charity affiliate, to develop Helping Mothers Deliver, an educational training course focusing on control of post partum hemorrage. Inspired in part by discussions and participant meetings on the potential of mobile technology in the MNH field, the
Mobile Alliance for Maternal Action (MAMA) was formed in May 2011.
"The 2010 Summit was a forum in the true sense of the word as ancient Romans would have it, where social entrepreneurs, donors, and policymakers exchanged ideas on how to further the cause of better health and healthcare for all peoples, especially those in emerging market and developing countries.”
- May Tsung-Mei Cheng, Health Policy Research Analyst, Woodrow Wilson School of Public and International Affairs, Princeton University
Chris Viehbacher, CEO of sanofi-aventis,
pledged 100 million doses of H5N1 flu vaccine to the WHO for developing countries, furthering the important work of the 2007 Summit. Mel Spigelman, President
and CEO of the Global Alliance for Tuberculosis Development announced a partnership for TB drug development with Tibotec,
a subsidiary of Johnson & Johnson. Becton, Dickinson and Company teamed up with FIND to offer a price reduction
in the cost of liquid culture testing, which FIND CEO Giorgio Roscingo announced. The denial of a U.S. visa for invited Summit speaker Paul Thorn of the Tuberculosis Survival Project in the UK,
due to his HIV-positive status, led to the repeal of the U.S. travel ban against HIV positive individuals following efforts on his behalf by U.S. Senator Patty
Murray and Representative Jim McDermott. After meeting at the Summit, Jim Allen, Asia Pacific Medical Director, Chevron Corporation invited Patrizia Carlevaro, Head of International Aid Unit, Eli Lilly and Company and her colleagues to
speak about MDR-TB at the annual meeting of the MNC Medical Directors’ Council in China, which included participants from IBM, GE, General Motors, Continental, 3M, and Proctor & Gamble.
Merck & Co. and Qiagen’s new cervical cancer vaccination partnership, launched publicly in September 2009, originated from the first in-person
meeting between Mark Feinberg and Qiagen CEO Peer Schatz in June. Following discussions at the 2009 Summit,
the Critical Path to TB Regimens,
an unprecedented public-private partnership on TB drug development was announced in 2010.
"The Summit’s value was in catalyzing interest and enthusiasm among high-level people who had never before been engaged in this field. Driving down TB rates and halving TB deaths are key 2015 targets and necessary precursors to TB elimination—the 2009 Summit helped us focus our eyes on the prize.” - Mario Raviglione, Director, Stop TB Department, WHO
Tachi Yamada, President of Global Health at the Bill & Melinda Gates Foundation and
Mark Walport, Director of the Wellcome Trust, announced that they would work together with the food
industry to fund the creation of a
Nutrition Index. Implemented by GAIN,
this initiative examines the contributions of the food and beverage industry to global nutrition. Keizo Takemi,
former Japanese Senior Vice Minister of Health, labor and Welfare, described how he and other key Japanese leaders were
working to integrate nutrition into the G8 agenda. Inspired by the discussions at the 2008 Summit around the concern that erosion of trust among
various stakeholders in the infant feeding area was undermining the scale-up of complementary feeding products for infants,
Peter Singer, CEO of Grand Challenges Canada and Director of the McLaughlin-Rotman Centre for Global Health of the University Health Network and
University of Toronto, co-published
The Shared Principles of Ethics for Infant and Young Child Nutrition in the Developing World in 2010. Finally, CEOs
of major food and beverage companies pledged to support the WHO Action Plan on Diet and Physical Activity.
"Ultimately, this dialogue laid the foundation for major movements and initiatives like the GAIN Business Alliance expanding its role, more projects from the private sector around the 1,000 Days campaign to focus on the most vulnerable populations, and the inception of the Access to Nutrition Index, which will benchmark market channels and industry's increasing role in improving nutrition impact at scale."
- Marc Van Ameringen, Executive Director, GAIN
Margaret Chan, Director-General of the World Health Organization (WHO) announced the establishment of a WHO pre-pandemic flu vaccine stockpile. GlaxoSmithKline simultaneously pledged a 50 million-dose donation to the stockpile, and Baxter International, sanofi pasteur, and Omnivest also pledged to contribute to the effort. Eli Lilly revealed the establishment of the
“Lilly Not-For-Profit Partnership for TB Early Phase Drug Discovery” to fight MDR-TB. Sir William Castell, Chairman of the Wellcome Trust began talking with Mark Feinberg, Vice President for Medical Affairs and Health Policy at Merck & Co at the Summit and realized their organizations’ complimentary interests, resulting in the creation of a $145 million non-profit research institute to be formed in India. This institute, the MSD Wellcome Trust Hilleman Laboratories, will take promising vaccine ideas to the test stage and will optimize or adapt current vaccines so that they are more affordable or usable in lower-income countries.
"The 2007 Summit on avian flu—and the pre-meeting we co-hosted with the Summit organizers
in Beijing—produced an important new response paradigm for fast-tracking regulatory vaccine approval in emergency situations. That represents a critical step forward.”
- Yu Wang, Director, China CDC
The first two Summits challenged how we approach healthcare, shifting the focus from a late stage disease model to a focus on prevention, early detection, and early treatment of disease. At the inaugural Summit, Sir William Castell, then President and CEO of GE Healthcare and current Chairman of the Wellcome Trust, announced the Early Health Initiative (EHI), which offered policy-makers a dynamic way to determine cost-effective investments in health promotion. Lee Hartwell, President and Director of the Fred Hutchinson Cancer Research Center (and member of the Summit’s Executive Committee) co-launched the Partnership for Personalized Medicine (PPM), which leveraged the Summit’s distinct commitment to early health, engaging new players and increasing commitment to early health across the globe in tangible ways. NBR, the Summit secretariat, created the Forum for Personal Health to facilitate collaborations between the Summit and PPM, and that initiative catalyzed the 2009 establishment of a new Center for Sustainable Health at Arizona State University’s Biodesign Institute, now directed by Michael Birt, Executive Director of the Summit, with Lee Hartwell serving as the Chief Scientist.
"The friendships and partnerships that resulted are helping to move healthcare from being our greatest modern cost to becoming our greatest modern asset."
- William Castell, Chairman, Wellcome Trust
Impact Retrospectives
“As a result of the Summit, we’ll see vital collaboration and fruitful partnerships emerge, bringing important progress and viable solutions.”
- Paul Farmer, Co-Founder, Partners In Health
“The Summit offered an unusual and much-needed opportunity for making new contacts, meeting new partners, and finding essential support.
It’s about what I bring back—TB has no boundaries. I couldn’t not come to the Summit.”
- Colonel Vladimir Troitskiy, Head, Medical Department, Russian Federal Penitentiary Services
“The Summit emphasized for all of us the necessity of not standing on the sidelines... The friendships and partnerships that resulted are helping
to move healthcare from being our greatest modern cost to becoming our greatest modern asset."
- William Castell, Chairman, Wellcome Trust
"The Pacific Health Summit is one of the most interesting meetings for me... I meet people I would not normally be able to meet in one place.
It is a goldmine of ideas - that's the value added."
- Peter Piot, Director, London School of Hygiene and Tropical Medicine
Top
|
